Obesity in your twenties doubles your risk of dying young
Becoming obese before the age of 30 nearly doubles the risk of dying young, research has revealed.
Scientists found that people's twenties are by far the most harmful time of life to gain weight, as it results in 'cumulative' damage to vital organs that can cause a range of diseases.
The study, presented at the European Congress on Obesity in Malaga, Spain, looked at death rates among 620,000 adults in Sweden who had their weights monitored throughout their lives.
The participants tended to put on weight as they aged, but deaths were significantly higher if people had gained weight in early adulthood compared with middle age.
Between 17 and 29 was found to be the 'critical life stage' in which staying slim was vital to
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Reuters
an hour ago
- Reuters
Molecular Partners to cut workforce by a quarter
ZURICH, June 10 (Reuters) - Swiss biotech firm Molecular Partners (MOLN.S), opens new tab said on Tuesday that it plans to reduce its workforce by up to 40 positions, or around 24%, as part of a strategic review to boost operational efficiency and focus on key clinical assets. The company, which develops DARPin protein therapeutics - a new type of engineered protein drugs - said the cuts aim to extend its cash runway into 2028, beyond earlier guidance of 2027. CEO Patrick Amstutz said the move will support the advancement of pipeline candidates MP0533 and MP0712, with clinical data expected in the second half of 2025.
BBC News
2 hours ago
- BBC News
'World's first coral-friendly sunscreen' unveiled in Derby
Scientists at the University of Derby say they have developed a sunscreen which could help corals team was working on the creation of a science-backed standard for reef-friendly sun protection when their lab experiments showed including certain nutrients in eco-friendly sunscreens helped some coral species grow - with one species increasing by almost a academic study revealed eight in 10 creams which say they are reef or ocean-friendly have not been rigorously tested, and some include chemicals proven to cause coral Derby scientists hope their new reef protection factors of gold, silver and bronze will eventually set the global industry standard. When hundreds of swimmers hit the water at the same time around a quarter of their sunscreen immediately washes off and creates an oily layer in the water. The impact on coral reefs and the marine life they support can be reefs around the world face a multitude of threats from climate change and ocean acidification, and the Derby research team set out to target one of the most preventable "stressors" for these the University of Derby's Aquatic Research Facility, team leader Prof Michael Sweet demonstrated how a small dab of "bad" sunscreen can start to kill tiny coral samples within hours of being added to laboratory tanks."We only started this experiment this morning," he said, fishing out a plug where a small coral fragment seems to be disintegrating. "Compared to the control tank, you can already see the tissue sloughing off the coral skeleton." The research started because the team and its commercial partners wanted to create a robust sunscreen accreditation system shoppers could trust. That meant designing a scientifically-validated test which brands would have to pass before they could claim to be "coral friendly" and earn their "reef protection factor" (RPF) of gold, silver or when research began, the concept of a coral-friendly sunscreen seemed unlikely."Originally I didn't think this was going to be possible," Prof Sweet said. "When [the nutrient-dense sunscreen] started showing a positive impact we knew we were on to something big." As part of the research, PhD student Triona Barker was asked to measure how corals responded when exposed to sunscreen without toxic chemicals but with added minerals and nutrients. The cocktail of ingredients was based on components known to be beneficial for cream was first tested to ensure it was safe for humans."We then dosed nine tanks over the course of 16 weeks," Ms Barker explained."At first we saw a growth of 8%, so we left it a bit longer. After 16 weeks [one coral species] had grown by 29%." Prof Sweet added: "We're not only avoiding any harm, we're actually feeding the corals as well." Wary of being accused of cosying up to commercial companies, Prof Sweet was determined the research would be conducted as non-profit. That meant the university had to pay the cost of the testing. "That was important to me," said Prof Sweet. "I had to stand up in front of my peers and the public and say this is truly reef-safe, as we have shown it to be... reaching a scientific consensus was a massive milestone for us."The research paper showing the university's test design and results is open-access and is now being scientifically first product to be certified under the new gold accreditation has been supported by the Tourism Authority of Thailand which recently arranged to hand it out on beaches in Thailand in exchange for non-accredited sunscreen. Now the university has been offered a profit share in Stream2Sea's "Coral Care", with the money ring-fenced for an educational fellowship programme to be launched globally in project is designed to raise public awareness of how sunscreen can damage marine life, with booklets being sent out to 600 schools. They also want to encourage manufacturers of other potentially damaging products such as shampoos and cosmetics to seek accreditation.
BBC News
2 hours ago
- BBC News
New ultrasound forecast to cut Addenbrooke's treatment times
NHS patents will be the first in Europe outside a trial setting to have access to a liver cancer treatment described as "cutting-edge and non-invasive".Addenbrooke's Hospital in Cambridge will start using a histotopsy system, an ultrasound treatment that can be delivered in a single short session. It could potentially take no longer than 30 minutes with limited or no pain and a quick Sinker, chief executive of Cambridge University Hospitals (CUH), said the technology could make a "huge difference" and reduce cancer treatment times. The Edison Histotripsy System, made by US-based HistoSonics, is expected to be fully installed at CUH later this year. It will initially be used to treat patients with primary and secondary liver tumours, and research is exploring its potential on treating other hard-to-reach Sinker said: "Histotripsy is an exciting new technology that will make a huge difference to patients. "By offering this non-invasive, more targeted treatment, we can care for more people as outpatients and free up time for surgeons to treat more complex cases. "The faster recovery times mean patients will be able to return to their normal lives more quickly, which will also reduce pressure on hospital beds, helping us ensure that patients are able to receive the right treatment at the right time." The incisionless surgery uses pulsed sound waves to create "bubble clouds" from gases present in the targeted form and collapse in microseconds, creating mechanical forces able to destroys tumours without surgery, scalpels or has been procured following a donation to the University of Cambridge from the Li Ka Shing Foundation, a supporter of cancer research at the Deborah Prentice, vice-chancellor of the university, said: "Through his longstanding support of cancer research at Cambridge, Sir Ka-shing Li continues to make a significant impact on outcomes for cancer patients. "Cutting-edge technology such as this histotripsy machine allows Cambridge to remain at the forefront of understanding and treating cancer, a position we aim to strengthen further with Cambridge Cancer Research Hospital."Previously, 23 patients from Europe were recruited in a histotripsy clinical trial. More than 1,500 patients worldwide have received the treatment, mainly in the United States. Follow Cambridgeshire news on BBC Sounds, Facebook, Instagram and X.
